We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Ryan Fischer

Ryan T. Fischer MD

Section Chief, Hepatology and Transplant Medicine, Department of Gastroenterology, Liver Care Center, Children’s Mercy Hospital, Kansas City, Missouri

Ryan T. Fischer, MD, is a board-certified Pediatric Gastroenterologist and Transplant Hepatologist at Children's Mercy Hospital in Kansas City. He has a strong interest in translational research related to liver disease and transplantation and novel therapeutics to treat disordered inflammation in the liver. His background in the lab includes basic research in dendritic cell biology, antigen presentation and cell-based immunotherapy.

In collaboration with the University of Kansas’s Department of Microbiology, Immunology and Genetics, Dr. Fischer is working to harness the potential of regulatory T cells for the modulation of liver allograft rejection. Clinically, he focuses on the diagnosis and treatment of liver disease in children, with a great deal of time devoted to children who need or have undergone liver transplantation. His hepatology team specializes in fatty liver disease, drug-induced liver injury, progressive liver fibrosis, and liver disease related to congenital heart disease.

Disclosures

Dr. Fischer has no relevant disclosures.